Print Page | Contact Us
Inside AzNA
Blog Home All Blogs
Search all posts for:   

 

View all (1358) posts »
 

E&R: Consequence of FDA Changes to Critically Ill Bedside Glucose Testing Regulations

Posted By Administration, Friday, January 11, 2019

 

February 7, 2019 11AM Arizona Time  |   Webinar

Nova StatStrip is FDA cleared and CLIA waived for use with all patients including critically ill. Use of all other meters with any critically ill patient population is considered off label by FDA and CMS. Hospitals cannot change FDA off-label testing designations using their own testing or definitions. This presentation will discuss the history and rationale for recent FDA changes to critically ill bedside testing and the regulatory and legal consequences of off-label testing to caregivers and hospitals.  More Information


 

Note from AzNA: We value our relationship with the community and are pleased to list healthcare related events occurring in Arizona. Posting of these events does not automatically carry CE credit for nurses nor have they been officially endorsed by AzNA.  If you have an event you would like included on the AzNA website and/or placed in the AzNA Today Weekly Newsletter, please submit an Event Inclusion Form.

This post has not been tagged.

Permalink | Comments (0)